S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

RPRX Royalty Pharma PLC

28.41

-0.35 (-1.22%)

04 May 2024 - Closed

Delayed by 15 minutes

Royalty Pharma beats on revenue

To read the full story on Seeking Alpha, click here.

Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Royalty Pharma Charts.

Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Royalty Pharma Charts.

Royalty Pharma PLC News

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Friday 19 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Royalty Pharma Declares Second Quarter 2024 Dividend
Wednesday 17 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Royalty Pharma Reports Q4 and Full Year 2023 Results
Thursday 15 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)

Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
Wednesday 31 January 2024 (3 months ago) • GlobeNewswire Inc.

Royalty Pharma Announces Dividend Increase
Saturday 20 January 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
Monday 8 January 2024 (4 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

More Royalty Pharma PLC News Articles

S&P ASX 300 Metals and M...

Australian SE All Ordina...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions